FSCN1 and prostate carcinoma: ,156 Moreover, lncRNA-PVT1, lncRNA-PCAT-1 and long intergenic noncoding RNA (LINC)00337 also act as ceRNA of miR-145 in esophageal and prostate cancer.168, 169, 170 In addition, lncRNA-TTN-AS1 enhances FSCN1 expression by competitively binding to miR-133b in esophageal cancer.160